Clinical feasibility of (neo)adjuvant taxane-based chemotherapy in older patients: analysis of >4,500 patients from four German randomized breast cancer trials

INTRODUCTION: Despite the fact that people older than 65 years of age have the highest incidence of developing breast cancer, these patients are excluded from clinical trials in most cases. Furthermore, most physicians tend towards therapy regimens without the use of dose-dense, highly active taxane...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Loibl, Sibylle, von Minckwitz, Gunter, Harbeck, Nadia, Janni, Wolfgang, Elling, Dirk, Kaufmann, Manfred, Eggemann, Holm, Nekljudova, Valentina, Sommer, Harald, Kiechle, Marion, Kümmel, Sherko
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2008
Témata:
Research Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2614510/
https://ncbi.nlm.nih.gov/pubmed/18796139
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/bcr2144
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky